Overview

Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The study will investigate how a new formulation of the study drug is absorbed, metabolised and distributed through the body, as well as its safety and tolerability in higher doses when given as single and multiple doses and as a single dose in the presence and absence of naproxen.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Naproxen